Webinars

• February 4, 2016: CIRM Scientific and Medical Accountability Standards Working Group Workshop on Human Gene Editing
• March 18, 2015: CAR-T Cell Immunotherapy: Challenges and Opportunities Using Mature or Stem Memory T Cells
• January 21, 2015: CIRM 2.0: We Are Changing the Way We Work
• September 11, 2014: Use of Induced Pluripotent Stem Cells as Screening Tools and Therapeutics
• November 14, 2013: Cell Therapies for Parkinson’s Disease from Discovery to Clinic
• June 20, 2013: Reimbursement Strategies Webinar
• April 15, 2013: Clinical Trials: Moving Stem Cell Based Therapies to the Clinic
• September 27, 2012: Immune Response in Stem Cell Therapies
• May 2, 2012: Focus on the Eye
• September 12, 2011: Scaffolding
• May 26, 2011: Imaging Technology for Cellular Therapies
• September 28, 2010: Preclinical Considerations for Stem Cell Therapies
• April 15, 2010: Issues in Product Characterization

Workshops

• February 24 & 25, 2022: CIRM Central Nervous System (CNS) Consortium Workshop
• January 13, 2020 Navigating Regenerative Medicine: Highlights from the CIRM-CURA Roundtable Conversation
• September, 26, 2019: Report on CIRM Grants Working Group Program Meeting
• April 15-16, 2019: Brainstorming Neurodegeneration Workshop
• February 4, 2016: CIRM Scientific and Medical Accountability Standards Working Group Workshop on Human Gene Editing
• September 2013: International Regulatory Considerations on Development Pathways for Cell Therapies [pdf]. Also available via AlphaMed Press.
• October 16, 2012: CIRM/RMC Roundtable Best Practices in Clinical Design for First-in-Human Stem Cell-Based Therapy
• July 10, 2012: NIH & FDA 2nd Public Workshop on Pluripotent Stem Cells in Translation: Early Decisions
• October 24, 2011: CIRM/RMC Roundtable on the Immune Response
• June 29, 2011 8-5pm: FDA CTGTAC Committee Meeting on Treatment of Retinal Disorders
• March 21, 2011: NIH & FDA Public Workshop on Pluripotent Stem Cells in Translation: Early Decisions
• November 2, 2010 8-5:30pm: FDA Public Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations

Contact us

If you have questions concerning any Webinar or Roundtable content, please contact:

Esteban Cortez
T: 510-899-03-42
E: ecortez@cirm.ca.gov